Cases 1 - 10 of 324
Celgene Corporation et al v. Prime Therapeutics LLC
as 1:2024mc00131
Petitioner:
Celgene Corporation and Bristol-Myers Squibb Company
Respondent:
Prime Therapeutics LLC
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01008
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. MSN Laboratories Private Limited et al
as 1:2023cv00699
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al
as 1:2023cv00459
Plaintiff:
Bristol-Myers Squibb Co., E. R. Squibb & Sons L.L.C., Ono Pharmaceutical Co., Ltd. and others
Defendant:
AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Accord Healthcare Inc.
as 1:2023cv00424
Plaintiff:
Celgene Corporation, Celgene International Srl, Bristol-Myers Squibb Company and others
Defendant:
Accord Healthcare Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Company et al v. Biocon Pharma Limited
as 1:2023cv00392
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Biocon Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Company et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv00393
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al
as 1:2023cv00079
Plaintiff:
Bristol-Myers Squibb Co. and E. R. Squibb & Sons, L.L.C.
Defendant:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al
as 1:2022cv00346
Plaintiff:
Bristol-Myers Squibb Co. and E. R. Squibb & Sons, L.L.C.
Defendant:
AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
